Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Pulmonary, Drug Sensitive”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT01225640
What this trial is testing

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Who this might be right for
Tuberculosis
Sequella, Inc. 59
Testing effectiveness (Phase 2)Study completedNCT03557281
What this trial is testing

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 76
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Testing effectiveness (Phase 2)UnknownNCT06224036
What this trial is testing

Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Drug-resistant Tuberculosis
Beijing Chest Hospital 52
Large-scale testing (Phase 3)Study completedNCT03338621
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 455
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Not applicableLooking for participantsNCT07164742
What this trial is testing

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

Who this might be right for
TB - TuberculosisTBTB Infection
Johns Hopkins University 690
Testing effectiveness (Phase 2)Active Not RecruitingNCT06058299
What this trial is testing

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Pulmonary TBPulmonary TuberculosisDrug Sensitive Tuberculosis
Global Alliance for TB Drug Development 309
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Testing effectiveness (Phase 2)Study completedNCT02381470
What this trial is testing

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Who this might be right for
Pulmonary Tuberculosis
National University Hospital, Singapore 58
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Study completedNCT03474198
What this trial is testing

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
University College, London 675
Testing effectiveness (Phase 2)Study completedNCT02279875
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 113
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Testing effectiveness (Phase 2)Study completedNCT04550832
What this trial is testing

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

Who this might be right for
Infections and InfestationsPulmonary Tuberculosis
LigaChem Biosciences, Inc. 76
Testing effectiveness (Phase 2)Study completedNCT02193776
What this trial is testing

To Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

Who this might be right for
Tuberculosis
Global Alliance for TB Drug Development 240
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Testing effectiveness (Phase 2)Ended earlyNCT04575519
What this trial is testing

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, MDRTuberculosis Infection
Fundació Institut Germans Trias i Pujol 426
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07467252
What this trial is testing

AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT

Who this might be right for
Pulmonary Tuberculosis
Ministry of Health, Saudi Arabia 200
Testing effectiveness (Phase 2)Looking for participantsNCT05807399
What this trial is testing

PanACEA - STEP2C -01

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 390
Load More Results